129 related articles for article (PubMed ID: 1289674)
1. Transforming growth factor beta 1 as a biomarker for prostate cancer.
Thompson TC; Truong LD; Timme TL; Kadmon D; McCune BK; Flanders KC; Scardino PT; Park SH
J Cell Biochem Suppl; 1992; 16H():54-61. PubMed ID: 1289674
[TBL] [Abstract][Full Text] [Related]
2. Transgenic models for the study of prostate cancer.
Thompson TC; Truong LD; Timme TL; Kadmon D; McCune BK; Flanders KC; Scardino PT; Park SH
Cancer; 1993 Feb; 71(3 Suppl):1165-71. PubMed ID: 8428340
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.
Timme TL; Truong LD; Slawin KM; Kadmon D; Park SH; Thompson TC
Microsc Res Tech; 1995 Mar; 30(4):333-41. PubMed ID: 7541677
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities.
Timme TL; Yang G; Truong LD; Kadmon D; Park SH; Thompson TC
World J Urol; 1995; 13(6):324-8. PubMed ID: 9116750
[TBL] [Abstract][Full Text] [Related]
6. Experimental oncogene induced prostate cancer.
Thompson TC; Kadmon D; Timme TL; Merz VW; Egawa S; Krebs T; Scardino PT; Park SH
Cancer Surv; 1991; 11():55-71. PubMed ID: 1726789
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis.
Timme TL; Truong LD; Merz VW; Krebs T; Kadmon D; Flanders KC; Park SH; Thompson TC
Endocrinology; 1994 Mar; 134(3):1039-45. PubMed ID: 8119140
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta expression in prostate neoplasia.
Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
[TBL] [Abstract][Full Text] [Related]
9. Retroviral transduction of transforming growth factor-beta1 induces pleiotropic benign prostatic growth abnormalities in mouse prostate reconstitutions.
Timme TL; Yang G; Rogers E; Kadmon D; Morganstern JP; Park SH; Thompson TC
Lab Invest; 1996 Apr; 74(4):747-60. PubMed ID: 8606485
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta 3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prostate carcinoma.
Djonov V; Ball RK; Graf S; Mottaz AE; Arnold AM; Flanders K; Studer UE; Merz VW
Prostate; 1997 May; 31(2):103-9. PubMed ID: 9140123
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
13. Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.
Merz VW; Miller GJ; Krebs T; Timme TL; Kadmon D; Park SH; Egawa S; Scardino PT; Thompson TC
Mol Endocrinol; 1991 Apr; 5(4):503-13. PubMed ID: 1922083
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia.
Wang L; Xie L; Tintani F; Xie H; Li C; Cui Z; Wan M; Zu X; Qi L; Cao X
Stem Cells Transl Med; 2017 Feb; 6(2):394-404. PubMed ID: 28191756
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of transforming growth factor-beta 1 and beta 3 as well as c-fos mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer.
Merz VW; Arnold AM; Studer UE
World J Urol; 1994; 12(2):96-8. PubMed ID: 7522082
[TBL] [Abstract][Full Text] [Related]
16. Expression of transforming growth factor-beta 1 in prostate cancer.
Steiner MS; Zhou ZZ; Tonb DC; Barrack ER
Endocrinology; 1994 Nov; 135(5):2240-7. PubMed ID: 7956947
[TBL] [Abstract][Full Text] [Related]
17. Alterations in mRNA levels for growth-related genes after transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma.
Egawa S; Kadmon D; Miller GJ; Scardino PT; Thompson TC
Mol Carcinog; 1992; 5(1):52-61. PubMed ID: 1543541
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in normal and malignant human prostate.
Perry KT; Anthony CT; Steiner MS
Prostate; 1997 Oct; 33(2):133-40. PubMed ID: 9316654
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L; Rowland RG; Lele SM; Kyprianou N
Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta 1 expression in benign and malignant prostatic tumors.
Glynne-Jones E; Harper ME; Goddard L; Eaton CL; Matthews PN; Griffiths K
Prostate; 1994 Oct; 25(4):210-8. PubMed ID: 7521962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]